These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6611336)

  • 1. Biochemical phenotype of 5-fluorouracil-resistant murine T-lymphoblasts with genetically altered CTP synthetase activity.
    Aronow B; Watts T; Lassetter J; Washtien W; Ullman B
    J Biol Chem; 1984 Jul; 259(14):9035-43. PubMed ID: 6611336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian mutants genetically altered in CTP synthetase activity.
    Aronow B; Ullman B
    Adv Exp Med Biol; 1986; 195 Pt B():263-9. PubMed ID: 3766230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to 5-fluorouracil associated with increased cytidine triphosphate levels in V79 Chinese hamster cells.
    Kaufman ER
    Cancer Res; 1984 Aug; 44(8):3371-6. PubMed ID: 6744271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for transformation-related increase in CTP synthetase activity in situ in human lymphoblastic leukemia.
    van den Berg AA; van Lenthe H; Busch S; de Korte D; Roos D; van Kuilenburg AB; van Gennip AH
    Eur J Biochem; 1993 Aug; 216(1):161-7. PubMed ID: 8365402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ regulation of mammalian CTP synthetase by allosteric inhibition.
    Aronow B; Ullman B
    J Biol Chem; 1987 Apr; 262(11):5106-12. PubMed ID: 2435724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic mutants of Chinese hamster cells with altered cytidine 5'-triphosphate synthetase.
    Chu EH; McLaren JD; Li IC; Lamb B
    Biochem Genet; 1984 Aug; 22(7-8):701-15. PubMed ID: 6497832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered CTP synthetase activity confers resistance to 5-bromodeoxyuridine toxicity and mutagenesis.
    Kaufman ER
    Mutat Res; 1986 Jun; 161(1):19-27. PubMed ID: 3702895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of the hamster thy mutator gene and its revertants.
    Trudel M; Van Genechten T; Meuth M
    J Biol Chem; 1984 Feb; 259(4):2355-9. PubMed ID: 6698969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to cyclopentenylcytosine in murine leukemia L1210 cells.
    Zhang H; Cooney DA; Zhang MH; Ahluwalia G; Ford H; Johns DG
    Cancer Res; 1993 Dec; 53(23):5714-20. PubMed ID: 7694793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of uridine-cytidine kinase and CTP synthetase in the synthesis of CTP in malignant human T-lymphocytic cells.
    van den Berg AA; van Lenthe H; Busch S; de Korte D; van Kuilenburg AB; van Gennip AH
    Leukemia; 1994 Aug; 8(8):1375-8. PubMed ID: 8057676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-step selection of mammalian cell mutants deficient in CTP synthetase.
    Li IC; Wu CL; Chu EH
    Somat Cell Mol Genet; 1989 Jan; 15(1):85-91. PubMed ID: 2916165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical pharmacology of acivicin in rat hepatoma cells.
    Lui MS; Kizaki H; Weber G
    Biochem Pharmacol; 1982 Nov; 31(21):3469-73. PubMed ID: 7150366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibition of cytidine triphosphate synthetase activity by cyclopentenyl cytosine in paediatric acute lymphocytic leukaemia.
    Verschuur AC; Van Gennip AH; Leen R; Meinsma R; Voute PA; van Kuilenburg AB
    Br J Haematol; 2000 Jul; 110(1):161-9. PubMed ID: 10930994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytidine triphosphate (CTP) synthetase activity during cell cycle progression in normal and malignant T-lymphocytic cells.
    van den Berg AA; van Lenthe H; Kipp JB; de Korte D; van Kuilenburg AB; van Gennip AH
    Eur J Cancer; 1995; 31A(1):108-12. PubMed ID: 7695960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutator phenotype in a mutant of S49 mouse T-lymphoma cells with abnormal sensitivity to thymidine.
    Roguska MA; Gudas LJ
    J Biol Chem; 1984 Mar; 259(6):3782-90. PubMed ID: 6706978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of action of 3-deazauridine in tumor cells sensitive and resistant to arabinosylcytosine.
    Brockman RW; Shaddix SC; Williams M; Nelson JA; Rose LM; Schabel FM
    Ann N Y Acad Sci; 1975 Aug; 255():501-21. PubMed ID: 171997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection and characterization of mutant S49 T-lymphoma cell lines resistant to phosphonoformic acid: evidence for inhibition of ribonucleotide reductase.
    Albert DA; Gudas LJ
    J Cell Physiol; 1986 May; 127(2):281-7. PubMed ID: 2939095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single point mutation in CTP synthetase of Chlamydia trachomatis confers resistance to cyclopentenyl cytosine.
    Wylie JL; Wang LL; Tipples G; McClarty G
    J Biol Chem; 1996 Jun; 271(26):15393-400. PubMed ID: 8663065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of temperature-sensitive cytidine triphosphate synthase mutations in bacteria by high-performance liquid chromatography.
    Bailey AJ; Dutta PK; Shanley MS; O'Donovan GA
    J Chromatogr; 1990 Jul; 512():403-7. PubMed ID: 2229235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts.
    Blaney SM; Grem JL; Balis FM; Cole DE; Adamson PC; Poplack DG
    Biochem Pharmacol; 1993 Apr; 45(7):1493-501. PubMed ID: 8471071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.